Tirzepitide is a dual agonist targeting GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. Enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and suppresses appetite through central and peripheral pathways.
It has attracted significant interest in metabolic and weight management research due to its potential impact on glucose homeostasis, appetite regulation, and energy expenditure.
In laboratory studies, Tirzepitide is valued for its high receptor affinity, multi-pathway action, and consistent bioactivity, making it a key compound in advanced metabolic and endocrine research protocols.
- Purity: ≥ 99 % (HPLC verified)
- Form: Lyophilized peptide powder
- Quantity: mg per vial vary according to product chosen
- Storage: Store lyophilized peptide at −20 °C; once reconstituted, refrigerate at 2–8 °C for up to 28 days
- Intended Use: For laboratory research only; not for human or animal consumption
Benefits
- Dual receptor agonist for advanced metabolic research
- Superior weight loss compared to GLP-1 agonists alone
- High purity and stability for consistent lab performance
- Manufactured in a cGMP-compliant facility
- COA available upon request
Disclaimer: This product is strictly intended for laboratory research use only. It is not for human consumption, medical use, or diagnostic applications.
Reviews
There are no reviews yet.